Published in
Wiley, British Journal of Haematology, 5(174), p. 748-759, 2016
DOI: 10.1111/bjh.14125
Links
Tools
A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysis
Journal article published in 2016 by
Neeraj Gupta,
Michael J. Hanley,
R. Donald Harvey 
,
Ashraf Badros,
Brea Lipe,
Vishal Kukreti,
Jesus Berdeja,
Huyuan Yang,
Xiaoquan Zhang,
Ai-Min Hui,
Mark Qian,
Karthik Venkatakrishnan,
Ajai Chari
,
Ashraf Badros,
Brea Lipe,
Vishal Kukreti,
Jesus Berdeja,
Huyuan Yang,
Xiaoquan Zhang,
Ai-Min Hui,
Mark Qian,
Karthik Venkatakrishnan,
Ajai Chari
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 